sponsored by Purdue Pharma, the maker of OxyContin, that downplayed the risks associated with prescription opioids, claiming that"there is no evidence that addiction is a significant issue when person
sponsored by Purdue Pharma, the maker of OxyContin, that downplayed the risks associated with prescription opioids, claiming that"there is no evidence that addiction is a significant issue when persons are given opioids for pain control."
In more recent years, Oz has adopted a more discerning tone toward opioids, particularly as a treatment of chronic pain. He and Roizen have written numerous syndicated columns suggesting that the risk of opioid addiction can be minimized by treating chronic pain with alternative measures such as meditation, exercise and acupuncture.